Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Inhalation Sciences Sweden

0.49

 

SEK

 

-1.21 %

Less than 1K followers

ISAB

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Compare
-1.21%
-14.98%
-39.07%
-69.36%
-71.29%
-83.73%
-92.86%
-94.75%
-94.07%

Inhalation Sciences Sweden, ISAB, is a research company. Today, the main focus is on the production and development of laboratory instruments. The instruments are used to measure particles in inhalation air, and to measure how the composition of the air affects the lungs. The company sells products under various trademarks, mainly on the European market. Inhalation Sciences Sweden was founded in 2004 and is based in Huddinge.

Read more
Market cap
22.3M SEK
Turnover
1.52K SEK
Revenue
11.05M
EBIT %
-45.97 %
P/E
-
Dividend yield-%
-
Financial calendar
29/8
2025

Interim report Q2'25

21/11
2025

Interim report Q3'25

All
Press releases
ShowingAll content types
Press releaseyesterday

Inhalation Sciences: Ny försäljningschef tecknar i den pågående företrädesemissionen

Inhalation Sciences Sweden
Regulatory press release5/28/2025, 6:00 AM

Inhalation Sciences meddelar sista dag för handel med uniträtter

Inhalation Sciences Sweden
Regulatory press release5/27/2025, 12:00 PM

Inhalation Sciences Sweden AB (publ) publicerar årsredovisning för 2024

Inhalation Sciences Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/27/2025, 12:00 PM

Inhalation Sciences AB (publ) releases Annual Report 2024

Inhalation Sciences Sweden
Press release5/27/2025, 6:00 AM

Inhalation Sciences utser Ulf Wedenberg till Chief Commercial Officer (CCO)

Inhalation Sciences Sweden
Press release5/27/2025, 6:00 AM

Inhalation Sciences appoints Ulf Wedenberg as Chief Commercial Officer (CCO)

Inhalation Sciences Sweden
Press release5/26/2025, 11:00 AM

Inhalation Sciences: Föreslagen styrelseledamot tecknar i den pågående företrädesemission

Inhalation Sciences Sweden
Regulatory press release5/26/2025, 6:00 AM

Inhalation Sciences: KALLELSE TILL ÅRSSTÄMMA I INHALATION SCIENCES SWEDEN AB (PUBL)

Inhalation Sciences Sweden
Press release5/22/2025, 3:01 PM

Inhalation Sciences: ISAB webbinarium - genomgång av de positiva resultaten från FDA-studien

Inhalation Sciences Sweden
Press release5/22/2025, 6:30 AM

Inhalation Sciences tecknar strategiskt avtal med USA-baserade BioLum Sciences och utökar sin närvaro och kommersiella räckvidd i USA för att främja in vitro-respiratorisk forskning

Inhalation Sciences Sweden
Press release5/22/2025, 6:30 AM

Inhalation Sciences Signs Strategic Agreement with U.S.-based BioLum Sciences, expanding U.S. Presence & Commercial Reach to Advance In Vitro Respiratory Research

Inhalation Sciences Sweden
Press release5/21/2025, 7:37 AM

Investor Studios: Inhalation Sciences VD Manoush Masarrat deltar på Invest Live 12.20

Inhalation Sciences Sweden
Regulatory press release5/19/2025, 6:00 AM

Idag inleds teckningsperioden i Inhalation Sciences företrädesemission

Inhalation Sciences Sweden
Regulatory press release5/16/2025, 6:00 AM

Inhalation Sciences AB (publ) publicerar delårsrapport för det första kvartalet 2025

Inhalation Sciences Sweden
Regulatory press release5/14/2025, 3:40 PM

Inhalation Sciences offentliggör informationsdokument och teaser i samband med företrädesemission av units

Inhalation Sciences Sweden
Regulatory press release5/14/2025, 6:00 AM

Inhalation Sciences tidigarelägger delårsrapporten för perioden jan - mar 2025

Inhalation Sciences Sweden
Regulatory press release5/8/2025, 1:05 PM

Kommuniké från extra bolagsstämma i Inhalation Sciences Sweden AB (publ)

Inhalation Sciences Sweden
Press release5/8/2025, 6:30 AM

Inhalation Sciences får nya IRS ordrar från återkommande kunder - ökad efterfrågan i linje med regulatoriska krav

Inhalation Sciences Sweden
Press release5/8/2025, 6:30 AM

Inhalation Sciences receives new IRS orders from returning customers - increased demand in line with regulatory requirements

Inhalation Sciences Sweden
Press release4/29/2025, 6:30 AM

Inhalation Sciences: Inbjudan till investerarpresentation för genomgång av de positiva resultaten från FDA-studien

Inhalation Sciences Sweden
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team